COVID-19 mRNA vaccine immunogenicity decay and breakthrough illness in adolescents and young adults with childhood-onset rheumatic diseases
JG Yeo, KL Teh, WN Chia, YX Book, SF Hoh… - …, 2023 - academic.oup.com
Objectives To evaluate the humoral immunogenicity for 6 months after the two-dose
coronavirus disease 2019 (COVID-19) mRNA vaccination in adolescents and young adults …
coronavirus disease 2019 (COVID-19) mRNA vaccination in adolescents and young adults …
Chinese expert consensus on diagnosis and treatment strategies for novel coronavirus infection in immunocompromised populations (2023 edition)
CR Ju, M Wang, J Yuan, Y Xu, W Xue… - International Journal …, 2024 - Wiley Online Library
Since the coronavirus disease 2019 (COVID‐19) was identified in 2019, it has caused more
than 664 million confirmed cases and more than 6.7 million deaths globally by January 20 …
than 664 million confirmed cases and more than 6.7 million deaths globally by January 20 …
Look after the COVID‐19 pandemic: Mortality rates among patients with rheumatic diseases
E Çimen Güneş, S Çolak, ZB Şenlik… - International Journal …, 2024 - Wiley Online Library
Abstract Aim Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection
may have a more severe course in patients with underlying disease or who have had …
may have a more severe course in patients with underlying disease or who have had …
Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with …
Y Zhang, P Xu, J Huang, Z Hu - International Journal of …, 2024 - Wiley Online Library
Aim The aim of this study was to investigate the clinical features of patients with rheumatic
and musculoskeletal diseases (RMDs) infected with severe acute respiratory syndrome …
and musculoskeletal diseases (RMDs) infected with severe acute respiratory syndrome …
Antibody responses following the surge of SARS-CoV-2 Omicron infection among patients with systemic autoimmune rheumatic diseases
N Xiang, YJ Li, MY Liu, QQ Wu… - … Advances in Practice, 2023 - academic.oup.com
Objectives The surge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variant Omicron infections has affected most Chinese residents at the end of 2022, including …
variant Omicron infections has affected most Chinese residents at the end of 2022, including …
Predictors of COVID-19 severity and outcomes in Indian patients with rheumatic diseases: a prospective cohort study
J Mathew, S Jain, T Susngi, S Naidu… - … Advances in Practice, 2023 - academic.oup.com
Objective There is dearth of data regarding the outcomes of coronavirus disease 2019
(COVID-19) among rheumatic and musculoskeletal disease (RMD) patients from Southeast …
(COVID-19) among rheumatic and musculoskeletal disease (RMD) patients from Southeast …
Breakthrough SARS-CoV-2 infections in immune mediated disease patients undergoing B cell depleting therapy
CM Calabrese, E Kirchner, EM Husni, BP Moss… - medRxiv, 2022 - medrxiv.org
Objectives Immunocompromised patients with immune mediated inflammatory diseases
(IMIDs), undergoing therapy with B cell depleting agents are among the most vulnerable to …
(IMIDs), undergoing therapy with B cell depleting agents are among the most vulnerable to …
Outcomes in systemic sclerosis patients hospitalized with COVID-19: Insight from the National Inpatient Sample
HA Cheema, A Akhlaq, B Mustafa… - … of Scleroderma and …, 2024 - journals.sagepub.com
Objective: COVID-19, a respiratory infection caused by the novel coronavirus SARS-CoV-2,
can cause varying degrees of illness ranging from mild respiratory illness to severe …
can cause varying degrees of illness ranging from mild respiratory illness to severe …
[HTML][HTML] The Evolving Role of the Rheumatology Practitioner in the Care of Immunocompromised Patients in the COVID‐19 Era
LH Calabrese, CM Calabrese, E Kirchner… - Arthritis & …, 2022 - ncbi.nlm.nih.gov
The impact of the global COVID-19 pandemic on the field of rheumatology has been
dramatic and broad-ranging. These effects include the pandemic's ongoing influence on …
dramatic and broad-ranging. These effects include the pandemic's ongoing influence on …
Bioinformatic assay reveal the potential mechanism of Guizhi-Shaoyao-Zhimu decoction against rheumatoid arthritis and mild-to-moderate COVID-19
Y Xu, Z Huang, G Wu, F Jin, S Lin, C Zhang… - Computer Methods and …, 2023 - Elsevier
Background and objective Patients with rheumatoid arthritis (RA) are more susceptible to
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than healthy population …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than healthy population …